Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127622681 | 12762268 | 1 | I | 20160912 | 20160912 | 20160920 | 20160920 | EXP | CA-ALEXION PHARMACEUTICALS INC.-A201606880 | ALEXION | 37.35 | YR | F | Y | 86.18000 | KG | 20160920 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127622681 | 12762268 | 1 | PS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 600 MG, QW | A80273G | 125166 | 600 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | /wk | |||||
| 127622681 | 12762268 | 2 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 900 MG, Q2W | AE7317B04 | 125166 | 900 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | QOW | |||||
| 127622681 | 12762268 | 3 | C | FOLIC ACID. | FOLIC ACID | 1 | Oral | 5 MG, QD | 0 | 5 | MG | QD | |||||||
| 127622681 | 12762268 | 4 | C | CALCIUM+VITAMIN D3 | 2 | Oral | UNK, QD | 0 | QD | ||||||||||
| 127622681 | 12762268 | 5 | C | HUMALOG | INSULIN LISPRO | 1 | Subcutaneous | UNK | 0 | ||||||||||
| 127622681 | 12762268 | 6 | C | HUMULIN NOS | INSULIN HUMAN | 1 | Subcutaneous | UNK, QHS | 0 | QD | |||||||||
| 127622681 | 12762268 | 7 | C | TYLENOL | ACETAMINOPHEN | 1 | Oral | 325 MG, PRN | 0 | 325 | MG | /yr | |||||||
| 127622681 | 12762268 | 8 | C | AMOXICILLINE /00249602/ | AMOXICILLIN | 1 | Oral | 500 MG, QD | 0 | 500 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127622681 | 12762268 | 1 | Paroxysmal nocturnal haemoglobinuria |
| 127622681 | 12762268 | 3 | Supplementation therapy |
| 127622681 | 12762268 | 4 | Supplementation therapy |
| 127622681 | 12762268 | 5 | Diabetes mellitus |
| 127622681 | 12762268 | 6 | Diabetes mellitus |
| 127622681 | 12762268 | 7 | Headache |
| 127622681 | 12762268 | 8 | Prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127622681 | 12762268 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127622681 | 12762268 | Inappropriate schedule of drug administration | |
| 127622681 | 12762268 | Poor venous access | |
| 127622681 | 12762268 | Vein rupture |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127622681 | 12762268 | 1 | 20130409 | 20130430 | 0 | |
| 127622681 | 12762268 | 2 | 20130508 | 0 | ||
| 127622681 | 12762268 | 3 | 19980101 | 0 | ||
| 127622681 | 12762268 | 4 | 19980101 | 0 | ||
| 127622681 | 12762268 | 5 | 2005 | 0 | ||
| 127622681 | 12762268 | 6 | 2005 | 0 | ||
| 127622681 | 12762268 | 7 | 20130410 | 0 | ||
| 127622681 | 12762268 | 8 | 20130401 | 0 |